Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: Analyses of synovial fluid from patients with osteoarthritis

Arthritis and Rheumatism

Volumn 42, Issue 1, 1999, Pages 129-136

  Ishiguro, Naoki ^a   Ito, Takayasu ^a   Ito, Hideo ^b   Iwata, Hisashi ^a   Jugessur, Hitenishi ^c   Ionescu, Mirela ^c   Poole, A Robin ^c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ito Orthopaedic Hospital   (Japan)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; COLLAGEN; COLLAGENASE; HYALURONIC ACID; KERATAN SULFATE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROCOLLAGEN; PROTEOGLYCAN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; COLLAGEN METABOLISM; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; JOINT DESTRUCTION; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYNOVIAL FLUID LEVEL;

AGED; CARTILAGE, ARTICULAR; COLLAGEN; COLLAGENASES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROTEASE INHIBITORS; PROTEOGLYCANS; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0032948307     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199901)42:1<129::AID-ANR16>3.0.CO;2-4     Document Type: Article

References (42)

1. Poole AR, Alini M, Hollander AH. Cellular biology of cartilage degradation. In: Henderson B, Edwards JCW, Pettipher ER, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995. p. 163-204.
2. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991;5:2145-54.
3. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP). and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
4. Cawston TE, Bigg HF, Hazleman BL. Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid. Ann Rheum Dis 1993;52:177-81.
5. Dahlberg L, Fridén T, Roos H, Lark MW, Lohmander LS. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture: synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metallo-proteinase-1. Br J Rheumatol 1994;33:1107-11.
6. Bläser J, Triebel S, Maasjosthusmann U, Römisch J. Krahl-Mateblowski U, Freudenberg W, et al. Determination of metallo-proteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. Clin Chem Acta 1996;244:17-33.
7. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
8. Loulakis P. Shrikhande A, Davis G, Maniglia CA. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular cartilage cultures: putative site(s) of enzymic cleavage. Biochem J 1992;284:589-93.
9. Ilic MZ, Hardley CJ, Robinson HC, Mok MT. Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 1992;294:115-22.
10. Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases and cathepsin B. J Biol Chem 1992;267:19470-4.
11. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid: evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglohular domain. J Clin Invest 1992;89:1512-6.
12. Ratclifffe A, Doherty M, Maini RN, Hardingham TE. Increased concentrations of proteoglycan components in the synovial fluids of patients with acute hut not chronic joint disease. Ann Rheum Dis 1988;47:826-32.
13. Lohmander LS, Dahlherg L, Ryd L, Heineg̊ard D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 1989;32:1434-42.
14. Hazell PK, Dent C, Fairclough JA, Bayliss MT, Hardingham TE. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 1995;38:953-9.
15. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M, Synovial fluid chondroitin and keratan sulfate epitopes, glycosaminoglycans, and hvaluronan in arthritic and normal knees. Ann Rheum Dis 1997;56:299-307.
16. Fawthrop F, Yaqub R, Belcher C, Bayliss M, Ledingham J, Doherty M, Chondroitin and keratan sulfate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis. Ann Rheum Dis 1997;56:119-22.
17. Carroll G. Measurement of sulfated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid. Ann Rheum Dis 1989;48:17-24.
18. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
19. Mankin HJ, Lippiello L. The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest 1971;50:1712-9.
20. Bayliss MT. Proteoglycan structure in normal and osteoarthritic cartilage. In: Kuettner KE, Schleyerbach R, Hascall VC, editors. Articular cartilage biochemistry. New York: Raven Press; 1986. p. 295-308.
21. Rizkalla G, Reiner A, Bogoch E, Poole AR. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 1992;90:2268-77.
22. Poole AR, Ionescu M, Swan A, Dieppe PA. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan: implications for pathogenesis. J Clin Invest 1994;94:25-33.
23. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
24. Nelson F, Reiner A. Ionescu M, Brooks E, Bogoch E, Poole AR. The content of the C-propeptide of type II collagen in articular cartilage is an index of synthesis of this molecule which is increased in osteoarthritis [abstract]. Trans Orthop Res Soc 1994;19:216.
25. Månsson B, Carey D, Alini M. Ionescu M, Rosenberg LC, Poole AR, et al. Cartilage and hone metabolism in rheumatoid arthritis: differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995;95:1071-7.
26. Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M, Procollagen II c-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. J Rheumatol 1996;23:1765-9.
27. Kodama S, Iwata K, Iwata H, Tamashita K, Hayakawa T, Rapid one-stop sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 1996;127:103-8.
28. Fujimoto N, Zhang J, Iwata K, Shima T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 1993;220:31-45.
29. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for humun matrix metallo-proteinase 2 (72-kDa gelatinase/type IX collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
30. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuehi E, Yoshida S, et al. A line-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
31. Thonar EJ-MA, Kuettner KE, Williams JM. Markers of articular cartilage injury and healing. In: Andrish JT. editor. Sports medicine and arthroscopy review: chondral injuries. New York: Raven Press; 1994, p. 13-28.
32. Mink JH, Levy T, Crues JV III. Tears of the anterior cruciate ligament and menisci of the knee: MR imaging evaluation. Radiology 1988;167:769-74.
33. Lohmander LS, Hoermer LA, Lark MA. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
34. Sharif M, Osborne DJ, Meadows K, Woodhouse SM, Calvin EM, Shepstone L. et al. The relevance of chondroitin and keratan sulfate markers in normal and arthritic synovial fluid. Br J Rheumatol 1996;35:951-7.
35. Dahlberg L, Ryd L, Heinegård D, Luhmander LS. Proteoglycan fragments in joint fluid: influence of arthrosis and inflammation. Acta Orthop Scand 1992;63:417-23.
36. Ishiguro N, Ito T, Obata K-I, Fujimoto N, Iwata H. Determination of stromelysin-1, 72 and 92 Kda type IX collagenase, tissue inhibitor of metalloproteinase-1 (TlMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 1996;23:1599-604.
37. Howard EW, Bullen E, Banda MJ, Preferential inhibition of 72- and 92-Kda gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13070-5.
38. Roughley PJ, White RJ. Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J Biol Chem 1980;255:217-24.
39. Sweet MBE, Thonar EJ-MA. Immelman AR. Solomon L. Biochemical changes in progressive osteoarthrosis. Ann Rheum Dis 1997;36:387-98.
40. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-90.
41. Hayakawa T, Yamashitu K, Tanzawa K, Uchijima E, Iwata K, Growth-promoting activity of tissue inhibitor of metalloproteimises-1 (TIMP-1) for a wide range of cells: a possible new growth factor in serum. FEBS Lett 1992:298:29-32.
42. Hayakawa T, Yamashita K, Ohuchi E, Shinigawa A. Cell growth-promotina activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994;107:2373-9.